Findings reveal an age-dependent progression of mitochondrial dysfunction in BAC-hR1441G SNc DA neurons, and dysregulation of calcium channels and uncoupling proteins emerges as a key mechanism contributing to bioenergetic failure, suggesting potential therapeutic targets to mitigate PD progression.
Abstract
Background
Mitochondrial dysfunction and oxidative stress are central to the pathogenesis of Parkinson's disease (PD), particularly affecting substantia nigra pars compacta (SNc) dopamine (DA) neurons. Here, we investigate how the R1441G mutation in leucine-rich repeat kinase 2 (LRRK2), a key genetic contributor to familial and sporadic PD, impacts mitochondrial function in midbrain DA neurons.
Methods
We employed a BAC transgenic mouse model overexpressing human LRRK2-R1441G (BAC-hR1441G) and crossed it with TH-mito-roGFP mice to enable mitochondria-targeted redox imaging specifically in DA neurons. Acute midbrain slices from 3-, 6-, and 10-month-old mice were imaged using two-photon microscopy to assess mitochondrial oxidative stress. In parallel, mitochondrial respiratory function, membrane potential flickering events, and expression of uncoupling proteins (UCP4/UCP5) were analyzed. Spatial transcriptomic profiling was performed using the GeoMx® Digital Spatial Profiler to uncover associated molecular alterations.
Results
We observed a progressive increase in mitochondrial oxidative stress in SNc DA neurons of BAC-hR1441G mice at 3, 6, and 10 months of age. This was accompanied by reduced respiratory complex activity, attenuated mitochondrial membrane potential flickering, and diminished expression of UCP4 and UCP5. Spatial transcriptomic analysis revealed dysregulation of genes linked to mitochondrial uncoupling, calcium signaling, and redox regulation in BAC-hR1441G SNc DA neurons.
Conclusions
These findings reveal an age-dependent progression of mitochondrial dysfunction in BAC-hR1441G SNc DA neurons. Dysregulation of calcium channels and uncoupling proteins emerges as a key mechanism contributing to bioenergetic failure, suggesting potential therapeutic targets to mitigate PD progression.
Data provide evidence of a specific window of time during which sustained α-synuclein burden results in direct α-synuclein-mitochondria interactions and nigral mitochondrial damage and a specific remodeling of molecular clock components occurs, providing a potential new mechanism contributing to metabolic and mitochond...
S. O’Sullivan, Adrian Kacperczyk-Perdyan, A. Ulusoy et al.· bioRxiv· 0 citations
This work generates human induced pluripotent stem cell-derived midbrain dopaminergic neurons using both a 2D differentiation protocol and a recently developed 3D method based on the microencapsulation of hiPSCs in small alginate/fibronectin beads.
A. Zanon, E. Kerschbamer, D. Riekschnitz et al.· Communications Biology· 0 citations
These findings suggest that HMGB1 is closely associated with the intersection of neuroinflammation and mitochondrial dysfunction in MPTP-induced parkinsonism, and supports the translational value of the zebrafish PD model for investigating complex neurodegenerative mechanisms.
Khairiah Razali, Mohd Hamzah Mohd Nasir, Jaya Kumar et al.· Academia Neuroscience and Br...· 0 citations
Findings support a model in which MCU-1-dependent elevation of [Ca2+]mito contributes to oxidative mitochondrial defects in PDR-1/Parkin-deficient muscle.
Masahiro Kawasumi, Mika Teranishi· Antioxidants· 0 citations
Astrocyte-specific mitochondrial dysfunctions and calcium dysregulation are identified as key features of LRRK2- and PRKN-related pathology, providing new insights into how glial metabolic alterations contribute to neurodegeneration in PD.
Giovanna C. Cavalcante, C. C. Caldeira da Silva, É. Vogt et al.· bioRxiv· 0 citations
DYNC1I1-targeting interventions attenuated PD-related phenotypes in cellular and mouse models and were accompanied by improved autophagic-lysosomal marker profiles and increased PI3K/AKT phosphorylation.
Yuyu Li, Li Xu, Hui Sun et al.· Brain Research Bulletin· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.